IDH1 and cancer: Since not all cancers in our study have biologically relevant wild-type counterparts available for comparison, we sought to identify common hyper- and hypomethylated probes in our IDH1/2 mutated tumors by identifying hyper- and hypomethylated probes, which are common across all six IDH1/2 mutated tumor types in our study.